| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 07/05/2012 | US20120171695 Spontaneously contracting fish cell aggregates, use thereof and method for the production thereof |
| 07/05/2012 | US20120171694 Predictive markers and biomarker panels for ovarian cancer |
| 07/05/2012 | US20120171693 Methods for Generating Novel Stabilized Proteins |
| 07/05/2012 | US20120171692 Composition For Use In Identification Of Bacteria |
| 07/05/2012 | US20120171691 Method for monitoring the bisulfite-mediated conversion of dna |
| 07/05/2012 | US20120171690 Transgenic Animals for Analyzing CYP3A4 Cytochrome P450 Gene Regulation |
| 07/05/2012 | US20120171689 Fuidi herd management schema |
| 07/05/2012 | US20120171688 Gene Expression Markers for Colorectal Cancer Prognosis |
| 07/05/2012 | US20120171687 Response Prediction in Cancer Treatment |
| 07/05/2012 | US20120171686 Methods for the identification of microrna and their applications in research and human health |
| 07/05/2012 | US20120171685 Buffers for the stable storage of nucleic acids |
| 07/05/2012 | US20120171684 Ddao compounds as fluorescent reference standards |
| 07/05/2012 | US20120171683 Analysis of fragmented genomic dna in droplets |
| 07/05/2012 | US20120171682 Method for detecting, identifying and/or quantifying carbon nanotubes |
| 07/05/2012 | US20120171681 Oligonucleotides, methods and kits for detecting and identifying vancomycin-resistant enterococcus |
| 07/05/2012 | US20120171680 Single-molecule pcr for amplification from a single nucleotide strand |
| 07/05/2012 | US20120171679 Method for Rapid Detection and Identification of Bioagents in Epidemiological and Forensic Investigations |
| 07/05/2012 | US20120171677 Compensation for spectral crosstalk in multiplex nucleic acid amplification |
| 07/05/2012 | US20120171676 HIGHLY SENSITIVE RAPID ISOTHERMAL METHOD FOR THE DETECTION OF POINT MUTATIONS AND SNPs, A SET OF PRIMERS AND A KIT THEREFOR |
| 07/05/2012 | US20120171675 Method for isolating nucleic acids |
| 07/05/2012 | US20120171674 Detection of Cells Expressing T1R2 Taste Receptor |
| 07/05/2012 | US20120171673 Sample analysis method and assay kit used therein |
| 07/05/2012 | US20120171672 Inflammatory bowel disease prognostics |
| 07/05/2012 | US20120171671 Chk2 polymorphism as a cancer marker |
| 07/05/2012 | US20120171670 Bcr-abl1 splice variants and uses thereof |
| 07/05/2012 | US20120171669 Assay and Compositions for Detection of Bacillus Anthracis Nucleic Acid |
| 07/05/2012 | US20120171668 Enhanced deposition of chromogens utilizing pyrimidine analogs |
| 07/05/2012 | US20120171663 System for Detection of Occult Murine Cytomegalovirus (MCMV) |
| 07/05/2012 | US20120171662 Simplified Device for Nucleic Acid Amplification and Method for Using Same |
| 07/05/2012 | US20120171661 Detection of Antigens |
| 07/05/2012 | US20120171660 Method for screening and purifying enterovirus, method for mass-producing enterovirus, and method for manufacturing enterovirus vaccine |
| 07/05/2012 | US20120171305 Response Prediction in Cancer Treatment Involving p53 Adapted Cancer Therapy |
| 07/05/2012 | US20120171302 Compositions and methods for inhibiting redox-sensitive gtpases |
| 07/05/2012 | US20120171238 S. aureus allergen |
| 07/05/2012 | US20120171225 Diagnostic Method for Predicting the Risk of Cancer Recurrence Based on Histone Macroh2A Isoforms |
| 07/05/2012 | US20120171221 Biomarkers for the early detection of autoimmune diseases |
| 07/05/2012 | US20120171220 Further use of protein kinase n beta |
| 07/05/2012 | US20120171219 Use of pkc-zeta as a breast cancer tumorigenic biomarker as well as a target for treatment of breast cancer |
| 07/05/2012 | US20120171204 Compositions and methods for the treatment and diagnosis of immune disorders |
| 07/05/2012 | US20120171196 Monoclonal antibodies that neutralize anthrax toxins |
| 07/05/2012 | US20120171194 Method of Cell Differentiation and Uses Therefor in Screening, Diagnosis and Therapy |
| 07/05/2012 | US20120171193 Diagnostic and Treatment Methods for Characterizing Bacterial Microbiota in Skin Conditions |
| 07/05/2012 | US20120171192 Methods and materials for modulating deubiquitinases and ubiquitinated polypeptides |
| 07/05/2012 | US20120171190 Methods for diagnosing chronic diarrhea through protein secretion analysis |
| 07/05/2012 | US20120171174 Methods of Inducing Tissue Regeneration |
| 07/05/2012 | US20120171168 Method for treating pancreatitis with mesenchymal stem cells |
| 07/05/2012 | US20120171153 Modified hyaluronidases and uses in treating hyaluronan-associated diseases and conditions |
| 07/05/2012 | US20120171144 Methods of treating, reducing and inhibiting the appearance of ageing in the skin |
| 07/05/2012 | US20120171133 Modulation of Dynein in Skin |
| 07/05/2012 | US20120171124 Screening methods for cognitive enhancers |
| 07/05/2012 | US20120167988 Composition and method for in-system priming microfluidic devices |
| 07/05/2012 | DE102010023156B4 In vitro-Testsystem für virale Infektionen In vitro assay system for viral infections |
| 07/05/2012 | DE102009050287B4 SERS-Substrat SERS substrate |
| 07/05/2012 | DE102009038520B4 Verfahren und Vorrichtung zur Zellprobendiagnostik Method and device for cell samples diagnostics |
| 07/05/2012 | CA2823621A1 Optimization of multigene analysis of tumor samples |
| 07/05/2012 | CA2823518A1 Articles and method for detecting a target microorganism |
| 07/05/2012 | CA2823348A1 Molecular profiling for cancer |
| 07/05/2012 | CA2823339A1 Protein biomarkers of late stage breast cancer |
| 07/05/2012 | CA2823337A1 Her3 protein srm/mrm assay |
| 07/05/2012 | CA2823334A1 Protein biomarkers of recurrent breast cancer |
| 07/05/2012 | CA2823290A1 Plant having increased resistance or susceptibility to 4-hppd inhibitor |
| 07/05/2012 | CA2823237A1 Methods and compositions for a soybean in-planta transient expression system |
| 07/05/2012 | CA2823194A1 Therapeutic and diagnostic methods involving biglycan and utrophin |
| 07/05/2012 | CA2823193A1 Quantitating high titer samples by digital pcr |
| 07/05/2012 | CA2823123A1 Ultrasonic cavitation derived stromal or mesenchymal vascular extracts and cells derived therefrom obtained from adipose tissue and use thereof |
| 07/05/2012 | CA2823090A1 Environmental biological allergen measurement method, and simple kit for measuring biological allergen |
| 07/05/2012 | CA2823065A1 Immunostimulatory oligodeoxynucleotides |
| 07/05/2012 | CA2822969A1 Comprehensive monoclonal antibody generation |
| 07/05/2012 | CA2822967A1 Methods to determine zygosity in a bulked sample |
| 07/05/2012 | CA2822960A1 Method for collecting microbial sample from solid surface using contactless partitioning system and apparatus for partitioning solid surface |
| 07/05/2012 | CA2822955A1 Methods of identifying aphid resistant soybeans |
| 07/05/2012 | CA2822798A1 Compositions and methods for identifying and differentiating viral components of multivalent shipping fever vaccines |
| 07/05/2012 | CA2822328A1 Modulation of dynein in skin |
| 07/05/2012 | CA2817374A1 Enhanced deposition of chromogens utilizing pyrimidine analogs |
| 07/05/2012 | CA2754477A1 Method for screening and purifying enterovirus, method for mass-producing enterovirus, and method for manufacturing enterovirus vaccine |
| 07/04/2012 | EP2472257A1 Specimen for detecting infiltrative large intestine tumors |
| 07/04/2012 | EP2472247A1 Display control device |
| 07/04/2012 | EP2471958A1 MicroRNA-based methods and compositions for the diagnosis and treatment of solid cancers |
| 07/04/2012 | EP2471957A1 New markers for cancer |
| 07/04/2012 | EP2471956A1 MicroRNA-based methods and compositions for the diagnosis and treatment of solid cancers |
| 07/04/2012 | EP2471955A2 Organism-specific hybridisable nucleic acid molecule |
| 07/04/2012 | EP2471954A1 Genetic susceptibility variants associated with cardiovascular disease |
| 07/04/2012 | EP2471953A1 Genetic polymorphisms associated with cardiovascular disorders and drug response, methods of detection and uses thereof |
| 07/04/2012 | EP2471952A1 Genetic polymorphisms associated with cardiovascular disorders and drug response, methods of detection and uses thereof |
| 07/04/2012 | EP2471951A1 Predicting cognitive development by gene methylation analysis |
| 07/04/2012 | EP2471950A1 Detection of digestive system cancer, stomach cancer, colon cancer, pancreatic cancer, and biliary tract cancer by means of gene expression profiling |
| 07/04/2012 | EP2471949A1 Method for the identification by molecular techniques of genetic variants that encode no D antigen (D-) and altered C antigen (C+W) |
| 07/04/2012 | EP2471946A1 Method for determining coagulation inhibitors |
| 07/04/2012 | EP2471945A1 Method for determining coagulation inhibitors |
| 07/04/2012 | EP2471944A1 Novel peptidase substrates |
| 07/04/2012 | EP2471926A2 Immunostimulatory oligodeoxynucleotides |
| 07/04/2012 | EP2471924A1 Methods and compositions involving microRNA |
| 07/04/2012 | EP2471923A1 Methods and compositions involving microRNA |
| 07/04/2012 | EP2471922A1 Methods and compositions involving microRNA |
| 07/04/2012 | EP2471921A1 Methods and compositions involving microRNA |
| 07/04/2012 | EP2471918A1 Screening method |
| 07/04/2012 | EP2471917A1 Polynucleotide derived from novel hepatitis c virus strain and use thereof |
| 07/04/2012 | EP2471916A1 Diagnosis marker, diagnosis method and therapeutic agent for amyotrophic lateral sclerosis, and animal model and cell model developing amyotrophic lateral sclerosis |
| 07/04/2012 | EP2471908A1 Method for culture of hepatocytes |
| 07/04/2012 | EP2471805A2 Compositions and assays to specifically detect nucleic acid of influenza virus A or B |